Filgrastim biosimilar (Biolotus Biotech)

非格司亭生物类似药（Biolotus Biotech）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Biolotus Biotech)

Drug Alias Name重组人粒细胞刺激因子（Biolotus Biotech）rhG-CSF (Biolotus Biotech)非格司亭生物仿制药（Biolotus Biotech）Recombinant human granulocyte colony stimulating factor (Biolotus Biotech)Kymun-CSF

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryBrazil

Original Approved Date2016/06/01

Country/TerritoryBrazil

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiolotus

China Registration ClassN/A

Develop Information

Active CompaniesBiolotus

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02